Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, Ariana T. Leonelli, View ORCID ProfileBrittany A. Petros, Taylor Brock-Fisher, Sabrina T. Dobbins, Bronwyn L. MacInnis, Amelia Capone, Nancy Littlehale, Julie Boucau, Caitlin Marino, Amy K. Barczak, Pardis C. Sabeti, View ORCID ProfileMichael Springer, View ORCID ProfileKathryn E. Stephenson
doi: https://doi.org/10.1101/2022.08.04.22278378
Eric Y. Dai
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
Kannon A. Lee
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
Audrey B. Nathanson
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
Ariana T. Leonelli
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
Brittany A. Petros
2Department of Systems Biology, Harvard Medical School, Boston, MA, USA
3Harvard-MIT MD/PhD Program, Boston, MA, USA
4Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
Taylor Brock-Fisher
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
Sabrina T. Dobbins
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
Bronwyn L. MacInnis
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
6Harvard T.H. Chan School of Public Health, Boston, MA, USA
Amelia Capone
7Beth Israel Lahey Health Primary Care, Chelsea, MA, USA
Nancy Littlehale
7Beth Israel Lahey Health Primary Care, Chelsea, MA, USA
Julie Boucau
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
Caitlin Marino
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
Amy K. Barczak
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
9Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
10Harvard Medical School, Boston, MA, USA
Pardis C. Sabeti
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
6Harvard T.H. Chan School of Public Health, Boston, MA, USA
11Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA
12Howard Hughes Medical Institute, Chevy Chase, MD, USA
Michael Springer
2Department of Systems Biology, Harvard Medical School, Boston, MA, USA
Kathryn E. Stephenson
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
10Harvard Medical School, Boston, MA, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted August 04, 2022.
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, Ariana T. Leonelli, Brittany A. Petros, Taylor Brock-Fisher, Sabrina T. Dobbins, Bronwyn L. MacInnis, Amelia Capone, Nancy Littlehale, Julie Boucau, Caitlin Marino, Amy K. Barczak, Pardis C. Sabeti, Michael Springer, Kathryn E. Stephenson
medRxiv 2022.08.04.22278378; doi: https://doi.org/10.1101/2022.08.04.22278378
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, Ariana T. Leonelli, Brittany A. Petros, Taylor Brock-Fisher, Sabrina T. Dobbins, Bronwyn L. MacInnis, Amelia Capone, Nancy Littlehale, Julie Boucau, Caitlin Marino, Amy K. Barczak, Pardis C. Sabeti, Michael Springer, Kathryn E. Stephenson
medRxiv 2022.08.04.22278378; doi: https://doi.org/10.1101/2022.08.04.22278378
Subject Area
Subject Areas
- Addiction Medicine (368)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2744)
- Dermatology (234)
- Emergency Medicine (414)
- Epidemiology (12392)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4256)
- Geriatric Medicine (394)
- Health Economics (699)
- Health Informatics (2752)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4032)
- Nursing (216)
- Nutrition (598)
- Oncology (2125)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1147)
- Primary Care Research (466)
- Public and Global Health (6647)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (420)
- Sports Medicine (352)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)